Nordic ListingsIssuer Report
Ambu A/S: Quarterly Trading Report 2025 Q3
Ambu A/S: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=bf06f713e5b2c826249f3f95b41381dea&lang=en&src=omxlink
Ambu A/S: Quarterly Trading Report 2025 Q3
Watch Ambu's latest callAmbu (Copenhagen:AMBU B) Q3 2026 Earnings Call · Replay · Aug 26Read the transcript of Ambu (Copenhagen:AMBU B) Q3 2026 Earnings CallStory so far
Earlier from Ambu
- AMBU_B: Ambitious strategy aims for global endoscopy leadership, 11%-13% CAGR, and 20%+ EBIT margin
- AMBU_B: Strong Q3 growth and raised guidance, despite FX and working capital headwinds
- Ambu A/S: Quarterly Trading Report 2024 Q4
- Ambu A/S: Quarterly Trading Report 2025 Q2
- Ambu rises as FDA issues import alerts on rival devices
Later from Ambu
- AMBU_B: Strong double-digit growth and margin expansion, with robust outlook despite FX and tariff headwinds
- Georg Fischer, Hypoport, Team Internet Group
- AMBU_B: Double-digit growth and innovation drive global endoscopy leadership ambitions
- AMBU_B: Strong Q1 growth in endoscopy and urology, with EBIT margin on track despite tariff and FX headwinds
- Ambu Share Buyback Program Ends
Follow Ambu into a list and get an email when it puts out news.
Follow Ambu